Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties
Klemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors
Klemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
Journal of Medicinal Chemistry
|
November 28, 2023
Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 Hydrolase
Gebhard Thoma, Christian Markert, Rainer Lueoend, et al.
ACS Medicinal Chemistry Letters
|
August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors
Klemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Journal of Medicinal Chemistry
|
February 18, 2010
1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonists
Leo Widler, Eva Altmann, René Beerli, et al.
Scientific Reports
|
October 21, 2017
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors
Shin Numao, Franziska Hasler, Claire Laguerre, et al.
Journal of Medicinal Chemistry
|
February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase
Gebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2016
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties
Klemens Hoegenauer, Nicolas Soldermann, Christina Hebach, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors
Klemens Hoegenauer, Nicolas Soldermann, Frédéric Zécri, et al.
Journal of Medicinal Chemistry
|
November 28, 2023
Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 Hydrolase
Gebhard Thoma, Christian Markert, Rainer Lueoend, et al.
ACS Medicinal Chemistry Letters
|
August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors
Klemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Journal of Medicinal Chemistry
|
February 18, 2010
1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonists
Leo Widler, Eva Altmann, René Beerli, et al.
Scientific Reports
|
October 21, 2017
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors
Shin Numao, Franziska Hasler, Claire Laguerre, et al.
Journal of Medicinal Chemistry
|
February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase
Gebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Page
of 2